Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of NOVA22007 (ciclosporin 0.1%) ophthalmic cationic emulsion vs vehicle in moderate to severe dry eye syndrome
2007-000029-23Phase 3Completed
- Sponsor
- Novagali Pharma
- Start
- Apr 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dry eye syndrome (DED) comparing NOVA22007 (ciclosporin 0.1% ophthalmic cationic emulsion) with Vehicle ophthalmic cationic emulsion (2 arms). Primary endpoint: Corneal fluorescein staining (modified Oxford scale). Started Apr 2007; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2007-000029-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000029-23.